The Bionow Strategic Advisory Board is composed of senior individuals from across the North of England representing a cross-section of our membership and the sector as a whole. The Advisory Board advises Bionow offering sector relevant strategic advice and guidance.
The current membership of the Strategic Advisory Board is as follows:
- Chair: Mike Snowden, VP and Head of Discovery Science, AstraZeneca
- Graham Bond, Liverpool/Chester Office Managing Partner, RSM
- Chris Doherty, Independent
- Paul Found, COO, Fujifilm Diosynth Biotechnologies
- Catherine Headley, Head of Business Engagement and Knowledge Exchange, University of Manchester
- Andy Jones, Medicines Manufacturing Industrial Strategy Challenge Fund Director, Innovate UK
- Kath Mackay, Managing Director, Bruntwood SciTech Alderley Park
- Neil Murray, CEO, Impact Data Metrics
- Lloyd Payne, Independent
- Jonathan Perkins, Director : Global Development Lead, QIAGEN
- Linda Randall, Associate Vice President, Pharmaron
- Dave Simpson, CEO, Iksuda Therapeutics
- Joe de Sousa, Independent
- Jane Theaker, CEO, Kinomica
- Simon Wallwork, Partner, Slater Heelis
- Mark Wigglesworth, Volunteer Director MDC Lighthouse, Medicines Discovery Catapult
- Ceri Williams, Director of Research and Innovation Development, University of Leeds
- Peter Simpson, Chief Operating Officer, Medicines Discovery Catapult
- Jen Vanderhoven, Director, National Horizons Centre
- Steve McConchie, CEO, Aptus Clinical
- Jonathan O'Halloran, CEO, QuantuMDx
- Nige Hilton, Head of Manufacturing and Site Leader, Seqirus
Latest Jobs
